Guidance on applications for drug clinical trials under the interim order: Overview

Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 21:47 (TU)
Créé le avril 17, 2026, 21:47 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-04-28 00:00:00
open_canada_keywords {"fr": ["orientation", "document", "ordonnance provisoire", "coronavirus", "COVID-19", "essai clinique", "médicament", "réglementation", "phases d'essai clinique", "autorisation de médicament", "approbation de médicament"], "en": ["guidance", "document", "Interim Order", "coronavirus", "COVID-19", "clinical trial", "drug", "regulations", "clinical trial phases", "drug authorization", "drug approval"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Lignes directrices sur les demandes d’essais cliniques de médicaments au titre de l’arrêté d’urgence : Aperçu
update_frequency as_needed